1 |
Copper-catalyzed click chemistry reactions |
HA-hydrazine, collagen, and HA-aldehyde or HA-benzaldehyde, Copper (II) sulfate pentahydrate |
hMSCs |
Gelation in 5 min |
Enhanced focal adhesion, cell spreading, fiber remodeling |
Copper ions toxicity, reactive oxygen species generation, regional variation in viscosity due to rapid gelation, non-homogeneous gels |
[51] |
2 |
Diels–Alder click reactions |
Furan-linked gelatin against maleimide-linked PEG, chitosan-Pluronic F127) |
Cardiomyocyte cells, in vitro and in vivo
|
Gelation in 2 h, slower degradation rate in vitro
|
Injectable gels, fully-interpenetrating network, thermosensitive, cell adhesive |
Slow gelation, reduced solubility of the functional groups, inability to be injected in vivo in few cases |
[59] |
|
|
N-maleoyl alanine terminated F127, furan grafted chondroitin sulfate, oxidized chondroitin sulfate, bone morphogenetic protein-4 |
Rat mesenchymal stem cells, bone cells (repair), in vitro and in vivo
|
Gelation in 3 days, 14 days degradation in vitro
|
Easily modifiable, improved viscoelastic properties and rheological properties. Swellable, injectable, self-healing ability |
|
[61] |
|
|
Sodium alginate, bio glass and modified chondroitin sulphate |
Cranial bone defect repair, in vitro and in vivo
|
Gelation in 3 days, 4 weeks at neutral pH, faster degradation at basic pH in vitro
|
Triple cross-linked injectable hydrogel, better physio-chemical properties |
|
[60] |
|
|
Furfurylamine linked chondroitin sulfate, F127 linked maleimido and PEG-AMI, bone morphogenetic protein-4 |
Bone cells (repair) |
Gelation in Less than one min |
Non-covalent and covalent crosslinking, good biocompatibility |
|
[17] |
|
|
Furan linked HA, dexamethasone and maleimide linked HA |
Human adipose-derived stem cells, in vitro
|
Gelation in 60 min, more than 21 days for degradation in vitro
|
Thermo-responsible hydrogels, dexamethasone-controlled release in local environment, non-cytotoxic, can deliver adipogenic factors |
|
[57] |
|
|
HA with furan adipic dihydrazide, HA with furan CHO and followed by addition of dimaleimide PEG |
Chondrocyte cells (cartilage), in vitro
|
Gelation in 5 min |
Mechanical properties, tissue adhesive, self-healing, pH responsiveness |
|
[53] |
3 |
Strain-promoted azide-alkyne cycloaddition (SP-AAC) reactions |
Azadibenzocyclooctyne-modified dextran and azide-modified dextran |
Chondrocyte cells(cartilage), in vitro
|
Gelation in 1.1 to 10.2 min, slow degradation rate up to 21 days in vitro
|
Gelation time modifiable using concentration variation and substitution degree of dextran, encapsulation of cells and cell spheroids |
Reaction rate is lower than copper catalyzed reactions, alkynes are larger, trigger high perturbation, less ligation rate, high side reactions |
[72, 114] |
|
|
Dibenzocyclooctyl (DBCO)-modified HA, 4-arm PEG azide |
Chondrocyte cells (cartilage), in vitro and in vivo
|
Gelation in 10–14 min, slow degradation up to 35 days in vivo
|
Nontoxic cross linker, good biocompatibility, in situ physical gelation, elastic modulus can be modified by varying concentration |
|
[73] |
|
|
Hyperbranched poly(ε-caprolactone) (hyPCL)32-(1R,8S,9 s)-bicyclo[6.1.0]non-4-yn-9-ylmethanol (hyPCL32-BCN) and hyPCL32-azide (hyPCL32-N3) |
Bone (MC3T3 preosteoblast) cells |
Gelation in 30 min |
Injectable hyperbranched PCL, biocompatible, excellent support for cell adhesion and proliferation |
|
[71] |
|
|
4-dibenzocyclooctynol functionalized PEG, 4 arm PEG tetraazide, protein igands (laminin), neurogenic differentiation factor (interferon-γ) |
Neural stem cell, In vitro
|
Gelation in less than 5 min |
Additional differentiation factors not required in medium, high cell viability, no UV light required |
|
[16] |
4 |
Thiol-ene-based click chemistry reactions |
PEGDA, dithiothreitol, borox |
Endothelial cells and neural stem cells, in vitro
|
Gelation within few min of stirring |
Injectable, 3D printable, sacrificial removal enables tubular structure formation |
Polymer substrates lack alkenes with electron deficiency, acid condition required for the reaction |
[77] |
|
|
4-arm PEG norbornene, PEG dithiol, Protein array printing of collagen I, collagen III, collagen IV, fibronectin, laminin, elastin and hyaluronan |
Smooth muscle cells, in vitro
|
|
Cellular stiffness and increased functional contractility, cell attachment and 3D infiltration |
UV source needed in radical mediated reactions which may damage cells, oxygen sensitivity may result in disulfide formation; the presence of cysteine and amine group residues may compete with thiol group while hydrogel formation occurs. |
[82] |
|
|
Alkene-linked (allyl and norbornene residues), poly(oligoethylene glycol methacrylate)), cell adhesive peptides RGD and REDV |
Human umbilical vein endothelial cells (HUVECs), in vitro
|
|
Photo-patterned peptides at the surface, development of cell array is achieved |
|
[80] |
|
|
Norbornene-linked pectin macromer, monocysteine RGD peptide, biscysteine peptide with matrix metalloproteinase cleavage site |
Human neonatal dermal fibroblasts, in vitro
|
Degradation9 h in enzymatic treatment in vitro
|
Cell surface receptors in pectin may increase cell attachment and integration, simple, fast, robust, independent modification of the biochemical or biophysical cues in the system is possible |
|
[79] |
|
|
8-arm-PEG thiol macromer, thioester di(vinyl ether), caged thioester catalyst, norbornene RGD |
Primary hMSCs, in vitro
|
|
Dynamic, modifiable visco-elastic properties, using pH, stoichiometry and crosslinker structure the hydrogel network can be modified, thiol-ester resembles biological reactions |
|
[78] |
5 |
Oxime based click chemistry reactions |
Aminooxy-terminated PEGs, aldehyde modified HA and collagen I |
Schwann cells, HMSCs, in vitro
|
|
Less toxic to the cells, tunable properties, peptide, protein bonding is easier |
Not bio-orthogonal |
[22] |